Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases-百迪生物科技

首页 > 文献支持 > Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases

Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases

2025-06-08·文献支持

加入收藏去分享

发布日期： 2025-06-08

来源：

作者： Shengke Zhao, Yunjian Yu, Youtao Xin, Hegang Lu, Xiaohui Li a, Shuyu Wang, Feihe Ma, Hui Gao

加入收藏去分享

来源网址：https://www.sciencedirect.com/science/article/abs/pii/S1748013225001148

期刊：nanotoday丨丨引用百迪产品：H901001 1.5mL 微量离心管（PP，锥形底，未灭菌，无酶）& H803001 12孔细胞培养板（PS，TC处理，灭菌，无酶）

IF：13.2

日期：2025-06-09

GJB2 enhances cancer stem cell properties by modulating SOX2 expression via NF-κB pathway activation in lung adenocarcinoma

日期：2025-05-19

Exercise mimetic exosomes reestablish the extracellular matrix metabolic balance and alleviate the inflammatory macrophage infiltration in intervertebral disc degeneration

解决方案

关于百迪